Filtered By:
Source: Journal of NeuroInterventional Surgery
Education: Study
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 1069 results found since Jan 2013.
P145/93 Impact of collaterals status on outcomes of mechanical thrombectomy - in vitro study
ConclusionThe degree of collateral circulation may modify MT outcomes. Good collaterals might facilitate the achievement of FPR and prevent distal embolization.Disclosure of InterestMagda Jablonska has nothing to disclose.Jiahui Li has nothing to disclose.Riccardo Tiberi has nothing to disclose.Alejandro Tomasello reports receiving consulting fees from Anaconda Biomed, Balt, Medtronic, MicroVention, Cerus, Merlin Medical, and Stryker.Marc Ribo is a consultant for Medtronic, Cerenovus, Vesalio.
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Jablonska, M., Li, J., Tiberi, R., Tomasello, A., Ribo, M. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P146/118 NeVa ONE registry interim analysis: recanalization outcomes from a large, real-world patient cohort
ConclusionNeVa ONE Registry represents real-world data obtained from LVO AIS subjects treated with NeVa.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Bhogal, P., Diaz, J., Gallego, J. I., Dopico, M. S., Pfaff, J., Behme, D., Pero, G., Voormolen, M., John, S., Romero Florez, N. A., Celma, S. M., Waele, T. d., Francois, O., Cotroneo, E., Maleux, G. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P149/163 A comparative in vitro study of manual and robot-assisted mechanical thrombectomy
ConclusionIn experimental bench conditions, robot-assisted EVT performed by experienced neurointerventionalists is feasible and highly effective without inducing substantial procedural delays.Disclosure of InterestMR received research funding from Medtronic andVesalioMR declares ownership of Anaconda Biomed and Methinks shares. MR received consulting fees from Anaconda Biomed, Apta Targets, Medtronic, Stryker,Cerenovus, and Philips. AT reports receiving consulting fees from Anaconda Biomed,Balt, Medtronic, MicroVention, Cerus, Merlin Medical, and Stryker.
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Tomasello, A., Li, J., Tiberi, R., Rivera, E., Vargas, J. D., Losada, C., Diaz, L., Jablonska, M., Cendrero, J., Hernandez, D., Ribo, M. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P150/168 Acute ischemic stroke due to distal vessel occlusion treated with pREset LITE stent retriever. Single center experience
ConclusionOur Single-Center experience shows safety and efficacy of pREset stent retriever in MT for DVO. Further research is needed.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Fusaro, F., Corraine, S., Erta, M., Ferrari, A., Schirru, F., Zucca, S., Fenu, A., Comelli, S. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P151/175 Direct aspiration with EMBOVAC - first clinical experience and clot composition (results the "PERFECT study)
ConclusionThis is the first clinical evaluation of EMBOVAC. Direct aspiration with EMBOVAC as first line therapy resulted in high rates of reperfusion and favorable clinical outcomes. Clot composition analysis can aid in better understanding of the stroke etiology and means for effective clot removal.Disclosure of InterestAcandis (OJ, CL, JF); Microvention (GM, CC, JF); Stryker (GM, CC, JF); Medtronic (GM, CC, JF); Surge2surgery (BG); MIVI (CC); Phenox (CL, JF); Penumbra (CL, JF); GSK (AS); German Ministry of Science & Education and Economy & Innovation, EU, Hamburgische Investitions-/Förderbank, Philips, B...
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Lobotesis, K., Jansen, O., Marnat, G., Gory, B., Nordmeyer, H., Eckert, B., Alessandro, P., Cognard, C., Loehr, C., Bracco, S., Schaefer, A., Macera, A., Fiehler, J., Doyle, K., Piano, M. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P152/178 Safety and efficiency of bridging i.v. thrombolysis in M2 occlusions: a propensity-score-matched registry cohort study
ConclusionIn M2-occlusions, MT+IVT was not associated with increased risk of sICH. Patients receiving MT+IVT had lower 90d-mRS and a lower increase in mRS pre-stroke to 90d. However, probability of functional independence and rates of successful recanalization were similar compared to matched controls.Disclosure of InterestHK has financial interest in Eppdata GmbH.GT received fees as consultant and lecturer from Acandis, Alexion, Amarin, Boehringer Ingelheim, Bayer, BMS/Pfizer, Daiichii Sankyo and Portola. He serves in the board of the TEA Stroke Study and of ESO.JF is consultant for Cerenovus, Medtronic, Microvention, Pen...
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Kniep, H., Meyer, L., Broocks, G., Bechstein, M., Faizy, T., Winkelmeier, L., Brekenfeld, C., Flottmann, F., Paula Hanning, U. M., Thomalla, G., Fiehler, J., Gellissen, S. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P154/193 Impact of stent-retriever tip design on distal embolization during mechanical thrombectomy: a randomized in vitro evaluation
ConclusionsWhen facing fragment-prone clots, the filter-tip SR significantly reduces the number of large clots (>1 mm) that embolize distally during an MT procedure, potentially increasing the chances of first-pass complete recanalization.Disclosure of InterestMR received research funding from Medtronic andVesalioMR declares ownership of Anaconda Biomed and Methinks shares. MR received consulting fees from Anaconda Biomed, Apta Targets, Medtronic, Stryker,Cerenovus, and Philips. AT reports receiving consulting fees from Anaconda Biomed,Balt, Medtronic, MicroVention, Cerus, Merlin Medical, and Stryker. J-HBReceived consu...
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Li, J., Tiberi, R., Bhogal, P., Buhk, J.-H., Behme, D., Tomasello, A., Ribo, M. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P156/208 Association between arterial diameter and outcome in acute M2 occlusive ischemic stroke patients treated with endovascular thrombectomy
ConclusionThis study demonstrated that the lowest quartile of M2 diameter was associated with procedural complication in the acute M2 occlusion patients treated with EVT. However, clinical outcome was not differed.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Kim, J. Y., Kim, D. Y., Kang, J., Kim, B. J., Han, M.-K., Bae, H.-J., Baik, S. H., Jung, C. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P157/210 Comparison of adjustable vs self-expanding stent-retrivers for mechanical thrombectomy in large vessel occlusion
ConclusionTigertriever had a significantly higher successful first pass revascularization rate and shorter groin-to-revascularization time in the analysis done before and after propensity score matching with stent-like stent-retrievers.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Piasecki, P., Wierzbicki, M., Narloch, J., Debiec, A., Staszewski, J. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P158/212 The first pass effect: the initial real-life experience of the University Clinical centre of Serbia
ConclusionDespite shorter time intervals and higher frequency of recanalization rate of the FPE group, no difference was observed in relation to clinical and safety outcomes after 90 days of AIS. In order to better understand the FPE and its predictors, further studies are needed in form of randomized controlled clinical studies.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Mircic, U., Vukasinovic, I., Nedeljkovic, Z., Pirkovic, I., Nestorovic, D., Cvetic, V., Ercegovac, M., Jovanovic, D., Berisavac, I., Stanarcevic, P. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P159/213 Early clinical surrogates for functional outcome after mechanical thrombectomy in M2 occlusions compared to M1 occlusions
Conclusion24h NIHSS was identified as best surrogate for long-term functional outcome after thrombectomy for patients with M1 and M2 occlusion, while optimal cut-offs to predict good and excellent outcome were 1 NIHSS-point higher in M2 occlusions compared to M1 occlusions.Disclosure of InterestHK has financial interest in Eppdata GmbH.GT received fees as consultant and lecturer from Acandis, Alexion, Amarin, Boehringer Ingelheim, Bayer, BMS/Pfizer, Daiichii Sankyo and Portola. He serves in the board of the TEA Stroke Study and of ESO.JF is consultant for Cerenovus, Medtronic, Microvention, Penumbra, Phenox, Roche, Stryker...
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Kniep, H., Meyer, L., Broocks, G., Bechstein, M., Winkelmeier, L., Faizy, T., Brekenfeld, C., Flottmann, F., Paula Hanning, U. M., Thomalla, G., Fiehler, J., Gellissen, S. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P163/235 Thrombolysis and collateral flow in interhospital transfer for thrombectomy: implications for recanalization and infarct growth
ConclusionCollateral flow and thrombolysis may have a positive interaction in macrovascular recanalization. However, thrombolysis does not appear to interfere with collateral-mediated infarct growthDisclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Sousa, J., Bernardo-Castro, S., Machado, R. B., Maia, C., Cruz, L., Simoes, J., Martins, A. I., Bras, A., Almendra, L., Nunes, C., Machado, C., Rodrigues, B., Veiga, R., Nunes, C., Silva, F., Pereira R Cordeiro Santo, G. A., Machado, E., Freitas, J. S. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P164/236 Antithrombotic regimen in emergent carotid stenting for acute ischemic stroke due to tandem lesion: a meta-analysis of aggregate data
ConclusionsIn AIS due to tandem occlusion, the periprocedural antithrombotic regimen of eCAS seems to have a marginal effect on good functional outcome. Overall, high intensity antithrombotic therapy may provide a marginal benefit on good functional outcome and carotid stent patency without a significant increase in risk of sICH.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Diana, F., Abdalkader, M., Behme, D., Li, W., Maurer, C. J., Pop, R., Hwang, Y.-H., Bartolini, B., Ros, V. D., Bracco, S., Cirillo, L., Marnat, G., Katsanos, A., Kaesmacher, J., Fischer, U., Sousa, D. A. d., Peschillo, S., Zini, A., Tomasello, A., Ribo, M Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P165/237 Development and Validation of a novel stenosis model for percutaneous transluminal angioplasty training
ConclusionThe authors propose a novel ICA stenosis simulation model for training of PTA.The model provides a realistic and replicable method for standardized procedural training.Disclosure of InterestNothing to disclose
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Ramdani, N., Anna, K., Tuan, N., Jonte, S., Dieter, K., Fabian, F., Lukas, M., Jens, F., Maxim, B., Helena, G. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
P170/281 Endovascular thrombectomy with or without thrombolysis bridging in patients with acute ischemic stroke: a systematic review and meta-analysis of randomized trials
ConclusionLow-certainty evidence shows a small possible decrease in functional independence, low-certainty evidence shows a small possible decrease in mortality, and moderate-certainty evidence that there is probably a decrease in sICH for patients with EVT alone compared to EVT plus IVT.Disclosure of InterestThe authors have nothing to disclose.
Source: Journal of NeuroInterventional Surgery - August 21, 2023 Category: Neurosurgery Authors: Morsi, R. Z., Zhang, Y., Penagos, J. C., Desai, H., Tannous, E., Kothari, S., Khamis, A., Darzi, A. J., Tarabichi, A., Bastin, R., Hneiny, L., Thind, S., Coleman, E., Brorson, J. R., Mendelson, S., Mansour, A., Prabhakaran, S., Kass-Hout, T. Tags: 2.3 ISCHEMIC - Treatment Source Type: research
